These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28844122)

  • 1. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma.
    Jun BG; Kim YD; Cheon GJ; Kim ES; Jwa E; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Lee SH; Kim HS
    Korean J Intern Med; 2018 Nov; 33(6):1093-1102. PubMed ID: 28844122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
    Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
    Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm).
    Sun J; Zhang T; Wang J; Li W; Zhang A; He W; Zhang D; Li D; Ding J; Duan X
    BMC Cancer; 2019 Aug; 19(1):846. PubMed ID: 31455251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma.
    Wu ZF; Zhang JY; Shen XY; Zhou LY; Gao YB; Hu Y; Zeng ZC
    Med Phys; 2016 Jul; 43(7):4349. PubMed ID: 27370150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
    Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
    Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma.
    Hayashi K; Suzuki O; Wakisaka Y; Ichise K; Uchida H; Anzai M; Hasegawa A; Seo Y; Shimizu S; Ishii T; Teshima T; Fujimoto J; Ogawa K
    Radiat Oncol; 2024 Apr; 19(1):51. PubMed ID: 38649902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases.
    Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
    Radiat Oncol; 2018 Oct; 13(1):206. PubMed ID: 30348194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Values and Markers of Radiation-Induced Liver Disease for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Stereotactic Body Radiotherapy.
    Jia J; Sun J; Duan X; Li W
    Front Oncol; 2021; 11():760090. PubMed ID: 34970485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy.
    Barry A; McPartlin A; Lindsay P; Wang L; Brierley J; Kim J; Ringash J; Wong R; Dinniwell R; Craig T; Dawson LA
    Pract Radiat Oncol; 2017; 7(5):e331-e337. PubMed ID: 28442242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.
    Toesca DAS; Osmundson EC; von Eyben R; Shaffer JL; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(3):173-182. PubMed ID: 28343896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
    Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma.
    Lai YL; Kuo YC; Lai HC; Peng CY; Wang YC; Liang JA; Chen SW
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):437-443. PubMed ID: 26947774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.
    Yoon HI; Koom WS; Lee IJ; Jeong K; Chung Y; Kim JK; Lee KS; Han KH; Seong J
    Liver Int; 2012 Aug; 32(7):1165-71. PubMed ID: 22435801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.